Study of Olaparib/Trabectedin vs. Doctor’s Choice in Solid Tumors
Condition(s):Cancers With DNA Repair-DeficiencyLast Updated:August 29, 2023Active, not recruiting
Hide Studies Not Open or Pending
Condition(s):Cancers With DNA Repair-DeficiencyLast Updated:August 29, 2023Active, not recruiting
Condition(s):Colorectal CarcinomaLast Updated:April 11, 2018Terminated
Condition(s):GliomaLast Updated:November 7, 2018Completed
Condition(s):Colorectal Cancer; Neoplasm Metastasis; Liver MetastasesLast Updated:March 22, 2017Completed
Condition(s):PainLast Updated:September 25, 2017Unknown status
Condition(s):Rectal CancerLast Updated:May 7, 2015Completed
Condition(s):Children With Relapsed Solid Tumor, Lymphoma or LeukemiaLast Updated:April 11, 2018Completed
Condition(s):Pancreatic CancerLast Updated:September 25, 2014Terminated
Condition(s):Adenocarcinomas of the Esophagogastric JunctionLast Updated:April 11, 2013Terminated
Condition(s):Metastatic MelanomaLast Updated:August 12, 2016Completed
At TrialBulletin.com, we keep tabs on over 200,000 clinical trials in the US and abroad, using medical data supplied directly by the US National Institutes of Health. Please see the About and Contact page for details.